A Study on Safety and Efficacy of Sodium-glucose Cotransporter-2 Inhibitors as Adjuvant to Insulin Add-on Therapy in Uncontrolled Type 2 Diabetic Patients. AJP. 2018;12(03). doi:10.22377/ajp.v12i03.2625